These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10913807)

  • 1. Estimating significance level and power comparisons for testing multiple endpoints in clinical trials.
    Gong J; Pinheiro JC; DeMets DL
    Control Clin Trials; 2000 Aug; 21(4):313-29. PubMed ID: 10913807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Power and sample size for clinical trials when efficacy is required in multiple endpoints: application to an Alzheimer's treatment trial.
    Xiong C; Yu K; Gao F; Yan Y; Zhang Z
    Clin Trials; 2005; 2(5):387-93. PubMed ID: 16317808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statistical considerations for testing multiple endpoints in group sequential or adaptive clinical trials.
    Hung HM; Wang SJ; O'Neill R
    J Biopharm Stat; 2007; 17(6):1201-10. PubMed ID: 18027226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing the order of hypotheses in serial testing of multiple endpoints in clinical trials.
    Zhang Z; Wang C; Troendle JF
    Stat Med; 2015 Apr; 34(9):1467-82. PubMed ID: 25620627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A consistency-adjusted strategy for accommodating an underpowered primary endpoint.
    Huque MF; Alosh M
    J Biopharm Stat; 2012; 22(1):160-79. PubMed ID: 22204533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How to deal with multiple endpoints in clinical trials.
    Neuhäuser M
    Fundam Clin Pharmacol; 2006 Dec; 20(6):515-23. PubMed ID: 17109645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring mortality at interim analyses while testing a composite endpoint at the final analysis.
    Chen YH; DeMets DL; Lan KK
    Control Clin Trials; 2003 Feb; 24(1):16-27. PubMed ID: 12559639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and analysis for survival data under order restrictions with a modified logrank test.
    Liu PY; Tsai WY; Wolf M
    Stat Med; 1998 Jul; 17(13):1469-79. PubMed ID: 9695192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methods for the analysis of multiple endpoints in small populations: A review.
    Ristl R; Urach S; Rosenkranz G; Posch M
    J Biopharm Stat; 2019; 29(1):1-29. PubMed ID: 29985752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved two-stage group sequential procedures for testing a secondary endpoint after the primary endpoint achieves significance.
    Li H; Wang J; Luo X; Grechko J; Jennison C
    Biom J; 2018 Sep; 60(5):893-902. PubMed ID: 29876964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Power and sample size when multiple endpoints are considered.
    Senn S; Bretz F
    Pharm Stat; 2007; 6(3):161-70. PubMed ID: 17674404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weighted false discovery rate controlling procedures for clinical trials.
    Benjamini Y; Cohen R
    Biostatistics; 2017 Jan; 18(1):91-104. PubMed ID: 27445132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adaptive Designs with Discrete Test Statistics and Consideration of Overrunning.
    Schmidt R; Burkhardt B; Faldum A
    Methods Inf Med; 2015; 54(5):434-46. PubMed ID: 26429500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiplicity Adjustment and Sample Size Calculation in Clinical Trials with Multiple Endpoints: An Industry Survey of Current Practices in Japan.
    Sakamaki K; Morita Y; Iba K; Kamiura T; Yoshida S; Ogawa N; Suganami H; Tsuchiya S; Fukimbara S
    Ther Innov Regul Sci; 2020 Sep; 54(5):1097-1105. PubMed ID: 32030692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the statistical power for multiple tests: a case study.
    Yeo A; Qu Y
    Pharm Stat; 2009; 8(1):5-11. PubMed ID: 18381588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weighted multiple testing correction for correlated tests.
    Xie C
    Stat Med; 2012 Feb; 31(4):341-52. PubMed ID: 22114000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bonferroni-based correction factor for multiple, correlated endpoints.
    Shi Q; Pavey ES; Carter RE
    Pharm Stat; 2012; 11(4):300-9. PubMed ID: 22588983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some statistical methods for multiple endpoints in clinical trials.
    Zhang J; Quan H; Ng J; Stepanavage ME
    Control Clin Trials; 1997 Jun; 18(3):204-21. PubMed ID: 9204221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple comparisons in complex clinical trial designs.
    Hung HM; Wang SJ
    Biom J; 2013 May; 55(3):420-9. PubMed ID: 23620458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using prior information to allocate significance levels for multiple endpoints.
    Westfall PH; Krishen A; Young SS
    Stat Med; 1998 Sep; 17(18):2107-19. PubMed ID: 9789917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.